DekaBank Deutsche Girozentrale
ATRA icon

DekaBank Deutsche Girozentrale’s Atara Biotherapeutics ATRA Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio ATRA Stock Details ATRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,248
Closed -$231K – 1376
2022
Q2 		$231K Hold
1,248
– – ﹤0.01% 1161
2022
Q1 		$286K Buy
1,248
+112
+10% +$35.7K ﹤0.01% 1156
2021
Q4 		$476K Buy
1,136
+32
+3% +$13.5K ﹤0.01% 1107
2021
Q3 		$476K Hold
1,104
– – ﹤0.01% 1058
2021
Q2 		$419K Hold
1,104
– – ﹤0.01% 1107
2021
Q1 		$385K Hold
1,104
– – ﹤0.01% 1070
2020
Q4 		$575K Buy
1,104
+824
+294% +$380K ﹤0.01% 993
2020
Q3 		$89K Buy
+280
New +$95.4K ﹤0.01% 1135
2019
Q4 		– Sell
-288
Closed -$97K – 1147
2019
Q3 		$97K Sell
288
-288
-50% -$107K ﹤0.01% 916
2019
Q2 		$292K Buy
576
+224
+64% +$158K ﹤0.01% 975
2019
Q1 		$356K Buy
352
+64
+22% +$59.5K ﹤0.01% 969
2018
Q4 		$248K Sell
288
-64
-18% -$59.4K ﹤0.01% 937
2018
Q3 		$356K Sell
352
-8
-2% -$7.82K ﹤0.01% 991
2018
Q2 		$325K Hold
360
– – ﹤0.01% 984
2018
Q1 		$342K Sell
360
-8
-2% -$7.29K ﹤0.01% 928
2017
Q4 		$132K Hold
368
– – ﹤0.01% 970
2017
Q3 		$132K Hold
368
– – ﹤0.01% 976
2017
Q2 		$134K Hold
368
– – ﹤0.01% 949
2017
Q1 		$185K Buy
+368
New +$152K ﹤0.01% 849
2016
Q3 		– Sell
-648
Closed -$365K – 959
2016
Q2 		$365K Buy
648
+124
+24% +$59.5K ﹤0.01% 741
2016
Q1 		$246K Buy
+524
New +$236K ﹤0.01% 804

Other funds holding ATRA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.42B AUM 22.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

DekaBank Deutsche Girozentrale's ATRA Position: Q3 2022 in Review

DekaBank Deutsche Girozentrale sold out of Atara Biotherapeutics (ATRA) in Q3 2022, closing a stake of 1,248 shares — an estimated $231K sold.

DekaBank Deutsche Girozentrale first reported a position in ATRA in Q1 2016 and held it in 21 quarters. The position peaked at $575K in Q4 2020. 154 funds tracked by Wall St. Rank hold ATRA as of Q3 2022.

  • DekaBank Deutsche Girozentrale reported no remaining Atara Biotherapeutics position as of Q3 2022 after selling out during the quarter.
  • DekaBank Deutsche Girozentrale sold 1,248 Atara Biotherapeutics shares in Q3 2022, an estimated $231K.
  • DekaBank Deutsche Girozentrale first reported a position in Atara Biotherapeutics in Q1 2016 and held it in 21 quarters.
  • DekaBank Deutsche Girozentrale's Atara Biotherapeutics position peaked at $575K in Q4 2020.
  • 154 funds tracked by Wall St. Rank held Atara Biotherapeutics as of Q3 2022.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q3 2022, filed 2 Nov 2022.